Diversification of specific DNA segments typically involve in vitro generation of large sequence 33 libraries and their introduction in cells for selection. Alternative in vivo mutagenesis systems on 34 cells often show deleterious offsite mutations and restricted capabilities. To overcome these 35 limitations, we have developed an in vivo platform to diversify specific DNA segments based on 36 protein fusions between various base deaminases (BD) and the T7 RNA polymerase (T7RNAP) 37 that recognizes a cognate promoter oriented towards the target sequence. The transcriptional 38 elongation of these fusions generates transitions C to T or A to G on both DNA strands and in 39 long DNA segments. To delimit the boundaries of the diversified DNA, the catalytically dead 40 Cas9 (dCas9) is tethered with custom-designed crRNAs as a "roadblock" for BD-T7RNAP 41 elongation. While the efficiency of this platform is demonstrated in E. coli, the system can be 42 adapted to a variety of bacterial and eukaryotic hosts. 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58
. AID was fused at the N-and C-terminal ends of T7RNAP using a flexible peptide linker of Gly 156 and Ser (G3S)7, generating AID-T7RNAP and T7RNAP-AID fusions, respectively (Fig. 2b) . In 157 addition, variants of AID-T7RNAP were constructed with different N-terminal tags: thioredoxin 1 158 (TrxA; ~11 kDa) and a cytosolic version of the maltose binding protein (MBPc; ~40 kDa),
159
generating TrxA-AID-T7RNAP and MBPc-AID-T7RNAP, respectively (Fig. 2b) . N-terminal TrxA 160 and MBPc are reported to increase the solubility and expression level of protein fusions in E.
161
coli 42, 43, 44, 45 . Gene constructs encoding T7RNAP and AID fusions were placed under the control 162 of the tetracycline-regulated promoter (TetR-PtetA) 46, 47 in a low copy-number plasmid 163 (pSEVA221) 48 . MG*-URA3Dung bacteria harboring these plasmids, and pSEVA221 as negative 164 control, were grown at 37 o C in LB for 2 h (OD600 ~1.0), and induced with anhydrotetracycline 165 (aTc) for additional 1 h. All cultures grew to a similar final optical density (OD600 ~2.5), except 166 bacteria expressing native T7RNAP (OD600 ~1.2) suggesting some toxicity of T7RNAP 167 expression. Whole-cell protein extracts from these cultures were analyzed by Western blot with 168 a monoclonal antibody (mAb) anti-T7RNAP ( Fig. 2c ). Protein bands corresponding to the 169 expected size of full-length fusions and T7RNAP were detected in bacteria expressing all N-170 terminal AID fusions, albeit higher levels were found with MBPc-AID-T7RNAP. In the case of 171 the C-terminal fusion T7RNAP-AID, multiple protein bands were visible corresponding to 7 T7RNAP and truncated polypeptides derived from the fusion, but none corresponding to the full-173 length polypeptide (Fig. 2c ). GFP expression was detected by flow cytometry in bacteria with 174 native T7RNAP and all N-terminal AID fusions, but not in bacteria expressing the C-terminal 175 fusion of AID or carrying the empty vector (Fig. 2d ). GFP fluorescence was ca. 2-fold higher in 176 bacteria expressing native T7RNAP than in bacteria expressing any of the N-terminal AID 177 fusions (Fig. 2d) . Therefore, N-terminal fusions to T7RNAP produce a transcriptionally active 178 polypeptide in E. coli, whereas C-terminal fusions are not stable and transcriptionally inactive.
180
To test the mutagenic activity of the transcriptionally active fusions, cultures of MG*-URA3Dung 181 bacteria carrying plasmid constructs encoding none (empty vector control), AID-T7RNAP, TrxA-182 AID-T7RNAP, and MBPc-AID-T7RNAP, were grown and induced as above. After induction, 183 bacteria were plated on M9+uracil and M9+uracil+FOA to determine colony forming units 184 (CFU/ml) in each media. The mutation frequency of URA3 was determined for each bacterial 185 strain in three independent experiments as the ratio of FOA R CFU/ml vs. total CFU/ml ( Fig. 2e ).
186
These data revealed a significant increase (~1000-fold) in the frequency of FOA R bacteria 187 (URA3 mutants) in cultures expressing AID fusions (~10 -3 ) compared to negative control 188 bacteria (~10 -6 ). Interestingly, expression of native T7RNAP alone increased ~20-fold (~2x10 -5 ) 189 the frequency of URA3 mutants, suggesting some mutagenic activity caused by high-level 190 transcription of URA3 and/or by the toxicity of T7RNAP overexpression, which also caused a 191 ~10-fold reduction in the total CFU/ml ( Fig. 2f ). In contrast, bacterial cultures expressing AID 192 fusions did not show any significant change in total CFU/ml, with values similar to the control 193 strain (~10 9 CFU/ml) ( Fig. 2f ). Hence, the high-frequency of URA3 mutants found in bacteria 194 with AID fusions strongly suggests a mutagenic activity of the fusion polypeptides.
196
To evaluate the specificity of the mutagenic AID-T7RNAP fusions, bacteria from the above 197 cultures were also plated on rifampicin (Rif)-containing plates. Rif R colonies of E. coli are known 198 to contain mutations in rpoB, encoding the b-subunit of E. coli RNAP 49, 50 . The frequency of 199 mutation in rpoB was determined for each culture as the ratio of Rif R CFU/ml vs. total CFU/ml 200 ( Fig. 2g) . These data revealed a ~5-fold increase in the frequency of rpoB mutants in bacteria 201 8 expressing AID fusions (~10 -6 ) compared to the negative control or bacteria expressing native 202 T7RNAP (~2x10 -7 ) (Fig. 2g ). These data are in accordance with previous work showing that 203 expression of AID slightly increases the mutagenesis of non-specific loci in E. coli Dung strains 204 24 . However, this low non-specific mutagenic activity of AID-T7RNAP fusions is clearly 205 insufficient to explain the ~1000-fold increase in URA3 mutants, suggesting a strong specificity 206 of AID-T7RNAP fusions for the mutagenesis of URA3.
208
Mutagenic activity of different CDs fused to the N-terminus of T7RNAP. Since all fusions having 209 AID at the N-terminal of T7RNAP showed similar transcriptional and mutagenic activities ( Fig.   210 2), we chose the AID-T7RNAP fusion, lacking any additional protein partner, to continue our 211 work. We constructed similar N-terminal fusions with other CDs, namely pmCDA1 and 212 rAPOBEC1 ( Fig. 3a) . As for AID, pmCDA1 and rAPOBEC1 fusions were also cloned in 213 pSEVA221 under the control of TetR-PtetA. MG*-URA3Dung bacteria carrying pSEVA221 214 (negative control) or plasmids encoding T7RNAP, AID-T7RNAP, pmCDA1-T7RNAP, and 215 rAPOBEC1-T7RNAP, were induced with aTc. Western blot analysis of whole-cell protein 216 extracts from these cultures revealed similar expression levels of the fusion proteins, and higher 217 expression of native T7RNAP (Fig. 3b ), as before. Flow cytometry analysis also showed similar 218 levels of GFP expression in bacteria encoding AID, pmCDA1 and rAPOBEC1 fusions, with MFI 219 values roughly half of those found in bacteria expressing native T7RNAP ( Fig. 3c ). Hence, as 220 for AID-T7RNAP, fusions pmCDA1-T7RNAP and rAPOBEC1-T7RNAP were transcriptionally 221 active in E. coli.
223
Next, we determined the frequency of mutagenesis in URA3 and rpoB loci upon induction of 224 bacterial cultures carrying pSEVA221 (empty vector) or derivatives encoding native T7RNAP,
225
AID-, pmCDA1-and rAPOBEC1-fusions, in three different E. coli strains: MG*-URA3 (ung + ),
226
MG*-URA3Dung, and MG*-URA3DungDPT7 (lacking the PT7 in URA3). The ratio of FOA R CFU/ml 227 and Rif R CFU/ml vs. total CFU/ml for each induced culture was determined in three independent 228 experiments ( Fig. 3d ). This analysis showed a significative increase in the mutagenesis of the 229 URA3 locus for all CD fusions in Dung bacteria and in the presence of PT7. As expected from 9 previous data (Fig. 2) , the frequency of URA3 mutants in MG*-URA3Dung bacteria was ~10 -3 231 for AID-T7RNAP, ~10 -5 for native T7RNAP, and ~10 -6 for the empty vector, but increased 232 dramatically to ~5x10 -2 for rAPOBEC1-T7RNAP and to ~10 -1 for pmCDA1-T7RNAP. Thus, 233 rAPOBEC1 and pmCDA1 fusions have a higher mutagenic activity than AID fusion (~50-to 100-234 fold, respectively). The higher activity of rAPOBEC1 and pmCDA1 was also partially reflected in 235 a slighlty higher "off-target" mutagenesis in rpoB (Fig. 3d ). Importantly, the frequency of URA3 236 mutants for all CD fusions dropped to levels close to those of the empty vector in the strain 237 lacking the T7 promoter (MG*-URA3DungDPT7 strain). Hence, these data clearly indicate that 238 the strong mutagenic activity of CD-T7RNAP fusions in URA3 requires the presence of PT7. The 239 requirement of PT7 is also seen for the mutagenic activity of native T7RNAP in URA3 ( Fig. 3d ).
240
Lastly, we found that all CD fusions have a lower mutagenic activity in the ung + strain whereas 241 the mutagenic activity of native T7RNAP is independent of the presence of UNG ( Fig. 3d ). Not 242 surprisingly, the highly active pmCDA1 fusion also showed the highest mutagenic frequency of 243 URA3 in the ung + strain, with a 100-fold increase compared to the control with the empty vector 244 (frequency ~10 -4 vs. ~10 -6 ). A moderate increase of ~5 to 10-fold in the frequency of URA3 245 mutants was found in the ung + strain for AID and rAPOBEC1 fusions, respectively ( Fig. 3d ).
247
Mutagenic activity of an adenosine deaminase (AD) fusion to T7RNAP. To broaden the capacity 248 of the mutagenesis system to adenosine bases, a T7RNAP fusion was constructed with the 249 modified AD TadA7.10 (TadA*) 28 (Fig. 4a ). TadA* was shown to deaminate adenines in DNA 250 generating inosines that leads to A:T > G:C transitions. The fusion TadA*-T7RNAP was 251 expressed in MG*-URA3Dung at higher levels than AID-T7RNAP, as determined by Western-252 blot (Fig. 4b) . The TadA*-T7RNAP fusion was also transcriptionally active, producing slightly 253 higher levels of GFP than AID-T7RNAP (Fig. 4c ). The potential mutagenic capacity of TadA*-
254
T7RNAP was evaluated in different genetic backgrounds, using AID-T7RNAP as a positive 255 mutagenesis control and pSEVA221 vector as a negative control ( Fig. 4d) . These experiments 256 revealed that expression of TadA*-T7RNAP generates URA3 mutants with a frequency of ~2-257 5x10 -4 (~100-fold higher than the negative control) in both MG*-URA3(ung + ) and MG*-
258
URA3Dung strains, indicating that TadA* fusion is mutagenic and, contrary to AID-T7RNAP, 10 independent of the presence of the enzyme UNG ( Fig. 4d) . In E. coli K-12 the gene nfi encodes 260 endonuclease V, which is involved in inosine elimination 51, 52 . When TadA*-T7RNAP was 261 expressed in E. coli strains lacking nfi (MG*-URA3Dnfi and MG*-URA3DungDnfi), the frequency 262 of URA3 mutants further increased to ~10 -3 , a level similar to that generated by AID-T7RNAP in 263 the Dung mutant ( Fig. 4d ). In contrast, deletion of nfi had no effect over the mutagenesis 264 frequency of AID-T7RNAP ( Fig. 4d ). In addition, expression of TadA*-T7RNAP did not produce 265 any significant increase in the levels of off-target mutagenesis in rpoB in these strains compared 266 to the negative control (pSEVA221) ( Fig. 4d ). Lastly, we confirmed that the mutagenic activity 267 of TadA*-T7RNAP in URA3 was dependent on the presence of PT7 promoter since its 268 mutagenesis frequency dropped to the baseline levels in the strain MG*-URA3DungDPT7 ( Fig.   269 4e). Altogether these data demonstrate that TadA*-T7RNAP fusion has a specific mutagenic 270 activity for the target DNA having PT7. This mutagenic activity is independent of UNG, being 271 moderately increased 2-to 5-fold when endonuclease V is absent.
273
Characterization of the mutations produced by BD-T7RNAP fusions. We randomly picked 30 
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Showing correlation to the mutagenic capacity of the three CD-T7RNAP fusions, the highest 292 total number of mutations was found with pmCDA1-T7RNAP (426) followed by rAPOBEC1-293 T7RNAP (95) and AID-T7RNAP (42) (Fig 5c) . The total number of mutations found in the 30 294 URA3 alleles from TadA*-T7RNAP was 37, similar to that of AID-T7RNAP (Fig. 5c ). The average 295 number of mutations per clone presented the same hierarchy: pmCDA1-T7RNAP (14.2) > 296 rAPOBEC1-T7RNAP (3.2) > AID-T7RNAP (1.4) > TadA*-T7RNAP (1.2) ( Fig. 5d ). It is worth 297 noting that for all CD-T7RNAP fusions, transitions G to A were detected more frequently than C 298 to T in the URA3 coding strand (Figs. 5a and 5c). This indicates that CD-T7RNAP fusions 299 mutates more frequently Cs in the non-coding strand of URA3, which corresponds to the non-300 template strand for the CD-T7RNAP fusions ( Supplementary Fig. 3 ). This mutagenesis bias to 301 the non-template strand is less pronounced for AID-T7RNAP (62%) than for rAPOBEC1-302 T7RNAP (74%) or pmCDA1-T7RNAP (91%) (Fig. 5c ). In the case of TadA*-T7RNAP, we also 303 found a bias favoring T to C mutations in the coding strand of URA3 (84%), corresponding to A 304 to G mutations in the non-template strand for the TadA*-T7RNAP fusion ( Fig. 5c and 305 Supplementary Fig. 3 ). Therefore, DNA sequencing of URA3 mutant clones demonstrates that 306 CD and AD fusions induce the expected mutations with a variable bias towards the non-template 307 strand depending on the specific BD employed.
309
For a further analysis of the mutagenic process a 284 bp PCR fragment of the URA3 gene was 310 amplified from a culture of MG*-URA3Dung expressing AID-T7RNAP and was subjected to 311 massive next-generation sequencing (NGS; Materials and Methods). As a control, the same 312 region was amplified from an induced culture of MG*-URA3Dung carrying the empty plasmid 313 pSEVA221 and also subjected to NGS. The results of the variant call analysis from the two 314 samples (ca. 1x10 6 reads/sample) were compared and only the transition C:G to T:A appeared 315 in an statistically significant higher number of reads in bacteria expressing AID-T7RNAP
316
( Supplementary Fig. 4 ). Using an identical experimental approach, we analyzed the mutations the GFP-URA3 cassette (Fig. 6a) , and the new cassette was integrated in the flu locus of 331 MG*DpyrFDungDnfi. The resulting strain, named MG*-SacB-URA3DungDnfi, was sensitive to 332 sucrose with a frequency of spontaneous mutants of ca. 5x10 -6 . When AID-T7RNAP was 333 expressed in this strain the mutagenesis frequency of sacB increased to ~6x10 -4 334 ( Supplementary Fig. 6 ). The mutagenesis frequency of URA3 in this strain with AID-T7RNAP 335 (~1.7x10 -3 ) was similar to that observed in MG*-URA3DungDnfi (Fig. 4d) . These results confirm 336 that BD-T7RNAP fusions are able to mutate downstream regions to the target gene.
338
To delimit the mutagenesis of BD-T7RNAP fusions within the target gene, we investigated the 339 possibility of blocking elongation of T7RNAP with dCas9. dCas9 can bind a target DNA 340 sequence using a crRNA or gRNA and has been successfully used as transcriptional repressor 341 for the endogenous E. coli RNAP 54 . Importantly, co-expression of two gRNAs targeting the 
347
URA3DungDnfi was transformed with plasmid pdCas9 (without crRNAs) and derivatives 348 pdCas9-Tb.a and pdCas9-Tb.a.c. Then, these strains were transformed with the plasmid 349 encoding AID-T7RNAP or the empty vector pSEVA221. After growth and aTc induction the 350 levels of GFP expression were determined by flow cytometry (Fig. 6c ). The expression of the 351 double crRNAs Tb.a repressed GFP levels to ~30% and with the triple crRNAs Tb.a.c the levels 352 of GFP were further repressed to ~20%. The basal level of GFP expression in strains carrying 353 pSEVA221 was consider 0%. The protection of sacB from the BD-T7RNAP mutagenesis was 354 assessed by the ratio of mutation frequencies in sacB vs. URA3 in each of these strains. This 355 ratio was normalized as 1 for the strain expressing AID-T7RNAP and carrying pdCas9 without 356 crRNAs (Fig. 6d ). In concordance with the reduction of GFP expression detected by flow 357 cytometry, the mutagenesis of sacB dropped ~10 to ~14-fold when the double (Tb.a) and triple 358 (Tb.a.c) crRNAs were expressed, respectively (Fig. 6d) . These results demonstrate that the 359 dCas9 blockade can be used to limit the mutagenesis activity of BD-T7RNAP fusions mostly to 360 a target gene (or gene segment), significantly reducing the mutagenesis of downstream DNA 361 regions.
363

Discussion
364
In this work we have reported an in vivo mutagenesis system with high specificity for a target 365 gene based on the tethering of different BDs (AID, rAPOBEC1, pmCDA1 and TadA*) fused to 366 T7RNAP, which selectively recognizes its specific promoter (PT7) in reverse orientation at the 3'-367 end and that transcribes thorughout the target gene. Expression of the target gene is maintained 368 from its endogenous 5'-end promoter. The use of different BDs confers flexibility to the system 369 due to their different mutagenesis profile. Although the expression level and transcriptional 370 activity of CD-T7RNAP fusions were shown to be similar, their mutagenic capacity varied greatly 371 ranging from the least active fusion with AID (URA3 mutagenesis frequency of ca. 10 -3 ) to the 372 most active fusion with pmCDA1 (URA3 mutagenesis frequency of ca. 10 -1 ). The fusion bearing 373 rAPOBEC1 produced an intermediate URA3 mutagenesis frequency of ca. 10 -2 . This means 374 that the mutagenesis frequency of a particular target gene can be modulated using different CD-375 14 T7RNAP fusions. As expected, the mutations found in the target gene (URA3) by the CD-376 T7RNAP fusions were transitions C:G to T:A corresponding to the CD activity. In order to broad 377 the mutation spectrum to A:T base pairs in the target gene, we also constructed the fusion 378 TadA*-T7RNAP using the modified adenosine deaminase TadA7.10 (TadA*) 28 . This fusion was 379 expressed at higher levels than the CD-T7RNAP fusions, and was proved to generate bp 380 transitions A:T to G:C in the target gene (URA3) with a mutagenesis frequency of ca. 10 -3 , similar 
399
Elimination of the DNA repair enzymes UNG and endonuclease V (nfi) was important to obtain 400 optimal mutagenesis frequencies. It is well-known that UNG has a key role in reverting the 401 mutations caused by CDs, so this enzymatic activity was inhibited in other mutagenesis systems 402 based on CDs 18, 19 . In our case, when UNG was present the mutagenesis frequency dropped 403 between 500-fold for AID and 3000-fold for pmCDA1 and rAPOBEC. We deleted ung in our host 404 15 strains to ensure complete abrogation of UNG activity, but an interesting alternative to ung 405 deletion is its transient inhibition by expression of UGI (uracil N-glycosylase inhibitor) from 406 bacteriophage PBS2 25 . For the mutagenesis with TadA*-T7RNAP, the effect of the 407 endonuclease V was very mild. Only a decrease of 2-to 5-fold in the mutagenesis frequency 408 with TadA*-T7RNAP was detected in bacteria with endonuclease V. Therefore, it seems that 409 the removal of inosines generated by TadA* was much less efficient than removal of uracils 410 generated by CDs in the genomic DNA of E. coli. This was also observed in eukaryotic cells 411 subjected to mutagenesis with TadA* 28 . It is worth to mention that UNG did not affect the TadA*-412 T7RNAP mutagenesis nor did endonuclease V affect the mutagenesis of AID-T7RNAP fusion.
414
Another observation to be noted is that the mutagenic capacity of the BD-T7RNAP fusions 415 presented a bias towards the non-template strand. This phenomenon is less pronounced for 416 AID-T7RNAP but it is detected with all of them. The reason of this strand preference is unclear 417 but it may be caused by a better exposure of the cytosines or adenines on this strand in the 418 transcription bubble. The template strand could be less accesible due its insertion in the catalytic 419 core of the T7RNAP and the formation of the ssDNA:RNA hybrid 57 .
421
A key property of a targeted mutagenesis system is the specificity towards the on-target 422 sequence, keeping as low as possible the "off-target" mutagenesis to avoid the generation of 423 deleterious mutations in other parts of the genome. The specifity of the system was assesed by 424 two different approaches: monitoring mutations in the rpoB gene that conferred rifampicin 425 resistance and monitoring mutations in the URA3 gene in absence of the T7 promoter. We found 426 very high on-target vs. off-target ratios for all BD-T7RNAP fusions (ca. ≥ 10 3 ). Nevertheless, 427 some off-target mutagenesis is observed by the expression of these fusions. Compared to 428 mutations frequencies found in a host strain (e.g. Dung) without BD-T7RNAP fusion, the "off-429 target" mutagenesis increased moderately (ca. 2 to 5-fold) for AID-and TadA*-fusions and more 430 noticiable (ca. 10 to 20-fold) for pmCDA1-and rAPOBEC-fusions.
432 16
A different situation is caused by "off-target" mutations in downstream sequences (in relation to 433 the T7 promoter) of the target gene due to the high processivity of the BD-T7RNAP fusions. To 434 restrict the mutagenesis of BD-T7RNAP fusions to the target gene, we used dCas9 directed with 435 crRNAs to block transcriptional elongation. This strategy has been previously used to repress 436 gene expression in E. coli by blocking the endogenous RNA polymerase 54, 55 . It has been 437 reported that dCas9 blocks the E. coli RNAP when the crRNAs bind to the non-template strand 438 and the presence of two targeting crRNAs enhance the repression 55 . Keeping this in mind, we 439 designed three crRNAs targeting the non-template strand. We have shown that the 3 440 crRNAs/dCas9 complexes are able to inhibit elongation of BD-T7RNAP fusions and reduce ca. 441 14-fold the mutagenesis of adjacent downstream DNA (with respect to T7RNAP elongation).
442
Therefore, the protection from mutagenesis of dowstream regions was significant, yet it may be 443 improved with dCas9 variants having increased blockade activity 58 .
445
One interesting feature of the reported method is that it could be adapted for its use in different 446 hosts since BDs, T7RNAP and dCas9 have been expressed in different bacteria, yeast and 447 mammalian cells 18, 19, 21, 30, 31, 32 . For modulation of the DNA repair systems, the expression of 448 UGI would avoid the need of delete ung in host that are not E. coli. Elimination of nfi is not 449 essential because the mutagenesis with TadA*-T7RNAP is still significant in the presence of the 450 endonuclease V. However, the modified TadA* pairs with the endogenous TadA of E. coli to 451 render a full active enzyme 28 . Hence, for mutagenesis in hosts that lacks endogenous TadA, a 452 heterodimeric construct fusing TadA and TadA* is needed 28 . In mammalian cells incorporation 453 of a nuclear localization signal (NLS) may be also necessary for targeting these protein fusions 454 to the cell nucleus.
456
The system described in this work can be used for molecular evolution of different genes and 
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Generation of the reporter strains. The reporter strains for the mutagenesis system were 527 derived from the reference of E. coli K-12 strain MG1655 39 . The strain MG1655* with higher 528 sensitivity to FOA was generated by an oligo-mediated allelic replacement method 16 529 (Supplementary Methods). All the successive modifications were done over the MG1655* 530 genetic background. The genes pyrF, ung and nfi were deleted using the plasmids pGEpyrF, 531 pGEung and pGEnfi, respectively, by a marker-less genome edition strategy 37 . This strategy is F_GFPseq / R_T0ter ( Supplementary Table S6 ) with the GoTaq Flexi DNA polymerase 569 (Promega) by colony PCR following manufacturer's instructions. The resulting amplicon was 570 21 sequenced by the Sanger chain-termination method (Macrogen) using the same primers. The 571 resulting 2 reads per colony were mapped against the Ptac-URA3-PT7 reference sequence (942 572 bp) to detect variants using the program SeqMan Pro (DNAstar).
574
For deeper analysis of the variations in URA3, NGS sequencing analysis of a 200 bp region was 575 performed. To do this, genomic DNA was extracted from ~4.5 ml of each induced culture (~5 x 576 10 9 bacteria) using the GNOME DNA Kit (MP Biomedicals). One hundred ng of total genomic 577 DNA was used as template in a PCR reaction to amplify 284 bp of URA3 with the pair of primers 578 F_CS1_URA3 / R_CS2_URA3 that includes Illumina tags CS1 and CS2 (Supplementary Table   579 S6). The DNA amplification was carried out in 50 µl reactions using Herculase II Fusion DNA 580 polymerase (Agilent Technologies) following manufacturer's instructions. The amplicons were 581 sent to the Genomic Unit of the Madrid Scientific Park to be sequenced by the NGS platform 582 Illumina Miseq with paired-end (length > 2 x 300 bp) to acquire ~1,000,000 reads per sample.
583
These reads were processed with the program Bbmap (Bushnell et al., 2017, PMID: 29073143) 584 for merging the paired-end reads. The resulting merged files were pilep up against the reference 585 sequence using the program Samtools (Li et al., 2009, PMID: 19505943) , and the variants were Mann Whitney test ( Fig. 3d, Supplementary Figs. S4 and S5 ) and two-tailed Student's t-test
